MedPath

Efficiency of a blended care version of an effective diabetes diet

Conditions
obesity-related type 2 diabetes
type 2 diabetes
10018424
Registration Number
NL-OMON56623
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

• Type 2 Diabetes
• Age 18-75 years
• Overweight/Obesity (BMI>27 kg/m2)
• Smartphone with Android or iOS

Exclusion Criteria

• Pregnancy or lactation during the trial
• Severe psychiatric problems, use of antipsychotic drugs
• Significant cardiac arrhythmias; unstable angina; decompensated congestive
heart failure; carcinomas; major organ system failure; untreated
hypothyroidism; end-stage renal disease;
• Myocardial infarction, cerebrovascular accident or major surgery during the
previous 3 months.
• Corticosteroid induced diabetes (in patients still using corticosteroids)
• Using glucagonlike peptide-1 (GLP-1) medication for <3 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>- Difference in weight (%) between the control and intervention group after 1<br /><br>year. Weight will be measured, after removal of shoes using a Seca 888 compact<br /><br>digital flat scale.<br /><br>- Difference in costs, determined by the difference in costs of the treatment,<br /><br>as well as costs of health care and costs of production losses, measured by the<br /><br>Trimbos/iMTA Questionnaire for Costs (TiC-P) </p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath